Medistim ASA (LON:0OCD)

Medistim ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	122.88	103.83	103.82	113.97	90.9	69.39
Depreciation & Amortization	23.02	24.51	23.66	23.29	23.43	16.25
Other Amortization	0.62	-	-	-	-	6.89
Other Operating Activities	-2.01	2.01	5.69	12.91	9.83	3.17
Change in Accounts Receivable	5.32	5.32	27.35	-33.02	-11.15	4.7
Change in Inventory	-15.13	-15.13	-31.06	-16.92	15.25	-22.6
Change in Accounts Payable	1.95	1.95	0.61	11.27	-0.32	-1.3
Change in Other Net Operating Assets	3.15	20.61	-10.88	2	-0.57	-2.38
Operating Cash Flow	139.81	143.1	119.2	113.49	127.37	74.13
Operating Cash Flow Growth	-0.61%	20.06%	5.03%	-10.90%	71.82%	-7.77%
Capital Expenditures	-6.07	-6.07	-16.4	-9.25	-7.4	-7.45
Sale (Purchase) of Intangibles	-18.63	-18.63	-13.33	-11.85	-4.08	-3.19
Investing Cash Flow	-25.53	-24.69	-29.73	-21.1	-11.49	-10.64
Long-Term Debt Repaid	-	-9.12	-8.71	-7.31	-12	-9.68
Net Debt Issued (Repaid)	-9.22	-9.12	-8.71	-7.31	-12	-9.68
Common Dividends Paid	-82.41	-82.41	-82.18	-68.4	-54.64	-50.05
Other Financing Activities	-	-	-	5.4	7.59	1.39
Financing Cash Flow	-99.55	-91.53	-90.89	-70.3	-59.05	-58.35
Foreign Exchange Rate Adjustments	-1.54	-1.54	2.65	1.07	0.76	-
Net Cash Flow	13.18	25.34	1.23	23.15	57.6	5.15
Free Cash Flow	133.74	137.04	102.8	104.24	119.97	66.68
Free Cash Flow Growth	7.62%	33.30%	-1.38%	-13.11%	79.91%	-0.02%
Free Cash Flow Margin	22.14%	24.64%	19.73%	21.44%	28.71%	18.72%
Free Cash Flow Per Share	7.30	7.48	5.62	5.70	6.57	3.66
Cash Income Tax Paid	31	28.4	25.7	19.17	13.34	19.05
Levered Free Cash Flow	88.84	81.67	64.81	56.39	98.98	47.3
Unlevered Free Cash Flow	89.35	81.67	64.81	56.47	99.09	47.4
Change in Net Working Capital	8.47	0.07	11.28	34	-17.78	24.78

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.